News | March 02, 2022
SeQuent Scientific completes acquisition of Nourrie in Brazil
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
To be marketed by Strides Pharma Inc. in the US market
The grants are expected to be received over the next three years, commencing March 2022
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Subscribe To Our Newsletter & Stay Updated
